Break new ground in innovation with

India’s leading pioneers in
Nucleic Acid and Medicinal Chemistry

With specialized  and modified nucleosides, and innovative building blocks that drive breakthrough treatments, we’re committed to shaping the future of nucleic acid therapies and drug development.

Dr. Paidi Yella Reddy

Dr. Paidi Yella Reddy

Founder, President & CEO
Sapala Organics

Dr-sudhir

Dr. Sudhir Kumar Singh

Chief Executive Officer
Suven Pharma

Sapala is now part of Suven Pharma, a Global CDMO.

This coming together unlocks manufacturing scale-up and global commercialization capabilities, enhancing Sapala’s growth and elevating its pharmaceutical offerings.

drive the fast lane with an array of services
Let your Drug Discovery

drive the fast lane with an array of services

We offer a comprehensive range of specialized nucleic acid building blocks, heterocyclic compounds, drug delivery compounds, and Drug development.

Tailored solutions for Oligo Nucleotide synthesis using the modified phosphoramidites  that are synthesised using deep expertise in Nucleic Acid Chemistry

Tailored solutions for drug development and delivery, with deep expertise in developing oligo-based therapies that target diseases at the genetic level.

State-of-the art analytical facility with wide array of Orthogonal analytical techniques for serving the customers from early R&D to Pharma innovators.

Reach out to the only reliable ‘Go To’ in India

for unlocking the potentials of Nucleic acids

With 100+ years of leadership experience across nucleic acid chemistry, Sapala Organics has built a unique position in the Nucleic Acids market. Our extensive portfolio and cutting-edge technologies empower our clients to develop next-gen oligonucleotide drugs and therapies, including NCE (New Chemical Entity) programs using our expertise in Nucleic acid Building Blocks. Our comprehensive R&D capabilities, combined with manufacturing excellence, make us a trusted partner across the oligonucleotide value chain.

for unlocking the potentials of Nucleic acids
Next-Gen Gene Therapies
Ride the Next Wave of

Next-Gen Gene Therapies

As a leading CRO and CDMO in nucleic acid space, Sapala Organics is committed to driving innovation and delivering breakthrough solutions for its clients. Our team’s unparalleled experience, combined with our state-of-the-art facilities, ensures that we are ready to meet the growing demand for next-gen therapies. Whether you are looking for a development partner or specialized manufacturing, we are here to collaborate with you.

Catch a glimpse of What’s Happening at Sapala Organics

Catch a glimpse of What’s Happening at Sapala Organics